Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05805332
Other study ID # 2022-NHLHCRF-LX-01-0202-4
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 7, 2023
Est. completion date December 31, 2024

Study information

Verified date April 2023
Source China-Japan Friendship Hospital
Contact Mingming Deng, MD
Phone 86 18801336854
Email isdeng1017@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of observational study is to evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography. Participants will undergo pulmonary rehabilitation.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 31, 2024
Est. primary completion date October 31, 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - The age is between 40-80 years old - Patients with chronic obstructive pulmonary disease who meet the diagnostic criteria of GOLD guideline(2019) - There was no acute exacerbation in the past 12 weeks Exclusion Criteria: - Hypoxemia (oxygen partial pressure is less than 60mmHg or oxygen saturation is less than 88% at rest), or patients who need continuous oxygen inhalation, or patients with any contraindication to exercise test (refer to the American Thoracic Association/American Association of Thoracic Physicians exercise test guidelines) - Oral glucocorticoids - Receive long-term oxygen therapy prescription - Have participated in supervised exercise programs in the past 12 months - History of other lung diseases, including pneumoconiosis, bronchiectasis, tuberculosis, primary pulmonary hypertension, pulmonary embolism, interstitial lung disease - Diseases that restrict the active exercise ability of participants or involve skeletal, neuromuscular, cardiovascular or metabolic disorders of muscle activity, such as tumors, diabetes, muscle weakness, etc

Study Design


Related Conditions & MeSH terms


Intervention

Other:
pulmonary rehabilitation
The participants would undergo pulmonary rehabilitation.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
China-Japan Friendship Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Effectiveness of pulmonary rehabilitation training 6-minute walking distance (6MWD) baseline
Primary Effectiveness of pulmonary rehabilitation training 6-minute walking distance (6MWD) 1 week after pulmonary rehabilitation
Primary Effectiveness of pulmonary rehabilitation training COPD Assessment Test (CAT) score baseline
Primary Effectiveness of pulmonary rehabilitation training COPD Assessment Test (CAT) score 1 week after pulmonary rehabilitation
Primary Effectiveness of pulmonary rehabilitation training St. George's Respiratory Questionnaire (SGRQ) baseline
Primary Effectiveness of pulmonary rehabilitation training St. George's Respiratory Questionnaire (SGRQ) 1 week after pulmonary rehabilitation
Primary Effectiveness of pulmonary rehabilitation training modified Medical Research Council (mMRC) dyspnea scores baseline
Primary Effectiveness of pulmonary rehabilitation training modified Medical Research Council (mMRC) dyspnea scores 1 week after pulmonary rehabilitation
Primary Effectiveness of pulmonary rehabilitation training rectus femoris muscle strength via a dynamometer baseline
Primary Effectiveness of pulmonary rehabilitation training rectus femoris muscle strength via a dynamometer 1 week after pulmonary rehabilitation
Primary Effectiveness of pulmonary rehabilitation training 6-30-second sit-to-stand test baseline
Primary Effectiveness of pulmonary rehabilitation training 6-30-second sit-to-stand test 1 week after pulmonary rehabilitation
Secondary Forced Expiratory Volume in 1-second(FEV1) Pulmonary function test before pulmonary rehabilitation
Secondary Forced Expiratory Volume in 1-second(FEV1) Pulmonary function test 1 week after pulmonary rehabilitation
Secondary Ultrasonic elastic imaging of rectus femoris Ultrasonic elastography of skeletal muscle before pulmonary rehabilitation
Secondary Ultrasonic elastic imaging of rectus femoris Ultrasonic elastography of skeletal muscle 1 week after pulmonary rehabilitation
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy